Cargando…
The Association of Serotonin Toxicity with Combination Linezolid–Serotonergic Agent Therapy: A Systematic Review and Meta-Analysis
Linezolid (LZD) has a longstanding reported association with the onset of serotonin toxicity (ST), secondary to drug–drug interactions with serotoninergic agents. There have been no conclusive data supporting the incidence or contributing risk factors to date. The study evaluated the incidence of ST...
Autores principales: | SanFilippo, Savanna, Turgeon, Jacques, Michaud, Veronique, Nahass, Ronald G., Brunetti, Luigi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661260/ https://www.ncbi.nlm.nih.gov/pubmed/37987392 http://dx.doi.org/10.3390/pharmacy11060182 |
Ejemplares similares
-
Classification and Assessment of Medication Risk in the Elderly (CARE): Use of a Medication Risk Score to Inform Patients’ Readmission Likelihood after Hospital Discharge
por: SanFilippo, Savanna, et al.
Publicado: (2021) -
512. Does Time From COVID-19 Symptom Onset to Administration of Anti-spike Protein Monoclonal Antibody Predict Response?
por: SanFilippo, Savanna, et al.
Publicado: (2021) -
Serotonergic agents and linezolid: Impact of exposure to more than one agent concomitantly on risk of adverse effects
por: Yan, Xuping, et al.
Publicado: (2023) -
Comparative Efficacy of Early COVID-19 Monoclonal Antibody Therapies: A Retrospective Analysis
por: San Filippo, Savanna, et al.
Publicado: (2022) -
Serotonin Syndrome Induced by Combined Use of Sertraline and Linezolid
por: Hasani, Ramesh, et al.
Publicado: (2019)